Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
Clinical trial NCT04367311 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04367311
- Sponsor
- Nasser Hanna
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2024-08-06
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.